IRBESARTAN RANBAXY irbesartan 150 mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

irbesartan, Quantity: 150 mg

Disponible des:

Sun Pharma ANZ Pty Ltd

Designació comuna internacional (DCI):

Irbesartan

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; hypromellose; colloidal anhydrous silica; titanium dioxide; macrogol 4000

Vía de administración:

Oral

Unidades en paquete:

30, 90

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

- Indicated for the treatment of hypertension.,- Indicated for delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Resumen del producto:

Visual Identification: White to off-white, film-coated, oval-shaped, biconvex tablet debossed with 'I4' on one side and plain on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Registered

Data d'autorització:

2012-09-17